Screening for Healthcare Worker Colonization With Resistant Organisms

Abstract

Healthcare-associated infections (HAIs) pose a substantial threat to patient safety worldwide, with multidrug-resistant organisms (MDROs) significantly complicating infection control efforts. Colonization of healthcare workers (HCWs) with resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and multidrug-resistant Gram-negative bacilli may serve as a reservoir for nosocomial transmission. This review critically appraises the current evidence, mechanisms, and guideline recommendations regarding the screening of HCWs for colonization with resistant organisms, focusing on epidemiology, risk factors, diagnostic approaches, management strategies, and practical implications for clinical practice.

Introduction

Infection prevention is a cornerstone of modern healthcare. With the rise of antimicrobial resistance (AMR), healthcare settings face an urgent need to implement effective strategies to curb the transmission of resistant organisms. Healthcare workers interact closely with vulnerable populations, making them both potential vectors and victims of colonization. Screening for colonization among HCWs is a contentious subject, with significant implications for infection control policy, occupational health, and patient safety. This article synthesizes recent literature and guideline-based perspectives on the subject, aiming to provide clinicians, infection control teams, and hospital epidemiologists with an up-to-date resource for informed decision-making.

Epidemiology / Disease Burden

Resistant organisms such as MRSA, VRE, and extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales are endemic in many healthcare environments. Surveillance studies report HCW colonization rates of 1-15% for MRSA and 0.5-6% for VRE, with considerable variability based on geographic region, care setting, and infection control practices. Outbreak investigations frequently implicate colonized HCWs as contributors to nosocomial transmission, particularly in high-risk units such as intensive care, neonatal, and burn units. The burden of MDRO colonization among HCWs is amplified by asymptomatic carriage, prolonged persistence, and suboptimal adherence to hand hygiene or barrier precautions.

Pathophysiology

Colonization with resistant organisms occurs when bacteria establish a persistent but non-invasive presence on mucosal or cutaneous surfaces. MRSA commonly colonizes the anterior nares, throat, and hands, while VRE and resistant Gram-negatives primarily inhabit the gastrointestinal tract. The pathophysiology involves complex interactions between host defenses, bacterial adhesins, and environmental factors. Repeated exposure to colonized patients or contaminated fomites, breaches in skin integrity, and disrupted microbiota due to frequent antibiotic use further facilitate colonization. Unlike infection, colonization does not cause symptoms but increases the risk for subsequent infection or onward transmission.

Risk Factors

Risk factors for HCW colonization include frequent direct patient contact, especially with high-risk or colonized patients; employment in high-acuity care areas; failure to adhere to hand hygiene or personal protective equipment (PPE) protocols; chronic skin conditions; and recent or repeated courses of antimicrobial therapy. Institutional factors such as overcrowding, understaffing, and environmental contamination can also increase risk. Notably, transient carriage may be common, particularly after direct contact with colonized patients or contaminated surfaces, whereas persistent colonization is less frequent but more consequential for transmission dynamics.

Clinical Features

By definition, colonization is asymptomatic; HCWs are typically unaware of their carrier status unless identified through screening. However, colonization serves as a reservoir for potential self-infection, particularly in the presence of breaks in skin or mucosal barriers, as well as cross-transmission to patients or colleagues. In rare cases, heavily colonized individuals may develop minor skin lesions, such as impetigo or folliculitis, though these are not the norm. The clinical impact is therefore indirect, contributing to the risk milieu within healthcare settings.

Diagnosis

Screening for resistant organism colonization in HCWs relies on microbiological sampling of anatomical sites known for high carriage rates, such as nasal swabs for MRSA or rectal swabs for VRE and ESBL-producing organisms. Culture-based methods remain the gold standard, often supplemented by molecular techniques such as PCR for rapid detection and improved sensitivity. The diagnostic yield is influenced by sampling technique, anatomical site, and the frequency and timing of screening. Selective screening is generally considered in the context of outbreak investigations, high-risk units, or epidemiologic studies, rather than routine universal screening, due to cost-effectiveness and ethical considerations.

Treatment & Management

Management of colonized HCWs depends on the organism, the clinical context, and institutional policies. Decolonization protocols, such as intranasal mupirocin and chlorhexidine body washes for MRSA, may be employed, though efficacy is variable and recurrence is not uncommon. For VRE and multidrug-resistant Gram-negatives, decolonization is less effective and rarely attempted. Temporary work restriction or reassignment may be considered in cases of persistent colonization implicated in ongoing transmission or outbreaks, particularly in settings with highly vulnerable patients. Ongoing education, strict adherence to hand hygiene, and environmental cleaning are critical adjuncts to any decolonization effort.

Recent Advances / Emerging Therapies

Recent years have seen advances in rapid molecular diagnostics, allowing for point-of-care detection of colonization and informing timely infection control interventions. Whole genome sequencing (WGS) has enabled detailed tracking of transmission chains, including the identification of HCW-mediated spread during outbreaks. Novel decolonization agents and approaches, such as probiotic therapies and bacteriophage applications, are under investigation but not yet established in clinical practice. Additionally, behavioral interventions, such as targeted hand hygiene campaigns and improved PPE compliance, have shown efficacy in reducing transmission without the need for widespread HCW screening.

Guideline Recommendations

Professional societies and public health agencies, including the Centers for Disease Control and Prevention (CDC) and the Society for Healthcare Epidemiology of America (SHEA), generally recommend against routine screening of asymptomatic HCWs for resistant organism colonization outside of outbreak situations or high-risk settings. Screening may be justified when epidemiologic data strongly implicate HCWs in ongoing transmission, or in specialized units such as NICUs during outbreaks. Decisions to implement screening should be guided by risk assessment, resource availability, and institutional policy, with an emphasis on evidence-based interventions such as hand hygiene and environmental decontamination.

Conclusion

Screening for healthcare worker colonization with resistant organisms remains a nuanced issue that balances infection control needs with practicality, cost-effectiveness, and ethical considerations. While routine universal screening is not recommended, targeted approaches during outbreaks or in high-risk settings can play a pivotal role in curbing nosocomial transmission. Advances in diagnostics and a deeper understanding of transmission dynamics continue to inform best practices. Ultimately, robust infection prevention strategies, including hand hygiene and environmental cleaning, remain the foundation of MDRO control in healthcare settings.